January 26, 2026 — Gerber Products Company is initiating a voluntary recall of limited batches of Gerber® Arrowroot Biscuits out of an abundance of caution due to the potential presence of soft plastic and/or paper pieces that should not be consumed. The material comes from an arrowroot flour suppli
Similar Posts
OSRX Inc. Missoula, MT. 483 issued 11/14/2025
ask Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 11/14/2025
Short Title (70 char) OSRX Inc. Missoula, MT. 483 issued 11/14/2025
FEI Number 3014549846
Firm Name OSRX Inc
Record Type 483
State MT
Establishment Type Outsourcing FacilityFDA-TRACK: Biosimilar User Fee Act Procedural Response Goals Summary
FDA-TRACK: Biosimilar User Fee Act Procedural Response Goals SummaryFDA Clinical Trials Training Modules
This training represents regulatory intelligence that sets global standards for clinical research. The content reflects current FDA thinking, emerging guidance, and real-world regulatory experience, providing participants with the most reliable and up-to-date information available.Umovy may be harmful due to hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use Umovy, a product promoted and sold for joint pain on various websites, including www.umovy-usa.com, and possibly in some retail stores.CDER Conversation: Novel Excipient Review Pilot Program
FDA’s Center for Drug Evaluation and Research’s (CDER) Office of New Drugs (OND) recently launched a pilot program on Novel Excipient Review. The pilot program offers a new pathway for drug manufacturers to obtain FDA review of certain novel excipients (inactive ingredients)Report on the State of Pharmaceutical Quality
The mission of the Office of Pharmaceutical Quality is to assure that quality medicines are available to the American public. The annual Report on the State of Pharmaceutical Quality is intended to help characterize the quality of the U.S. drug supply chain. Learn more.